Hepatitis C virus (HCV) infection among individuals without a history of injection drug use (IDU) is “sizeable” despite the higher HCV rates among those with a history of IDU, according to study ...
Kezar Life Sciences said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in ...
Currently, there are no specific antiviral drugs available for treating hepatitis E virus (HEV) infection, which represents a global health burden, causing acute viral hepatitis with varying clinical ...